| |
|
|
| Name: |
Sands Capital Ventures LLC |
| City: |
ARLINGTON |
| State: |
VA |
| Zip: |
22209 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
13 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
NU |
Nu Holdings Ord Shs Class A |
1 |
- |
$0.00 |
$109,227,000 |
9,155,661 |
26.34% |
32,960,000 |
0 |
0.264 |
N/A |
|
|
PATH |
Uipath, Inc. |
4 |
- |
$18.98 |
$52,219,000 |
2,303,452 |
12.59% |
-4,999,000 |
0 |
0.54 |
N/A |
|
|
TXG |
10x Genomics, Inc. |
6 |
- |
$0.00 |
$18,081,000 |
481,770 |
4.36% |
-8,879,000 |
0 |
0.458 |
N/A |
|
|
ABOS |
Acumen Pharmaceuticals, Inc. |
7 |
- |
$0.00 |
$13,839,000 |
3,417,075 |
3.34% |
717,000 |
0 |
8.443 |
N/A |
|
|
ACRV |
Acrivon Therapeutics, Inc. |
8 |
- |
$7.95 |
$11,816,000 |
1,652,605 |
2.85% |
3,685,000 |
0 |
7.915 |
N/A |
|
|
TSHA |
Taysha Gene Therapies, Inc. |
10 |
- |
$0.00 |
$2,080,000 |
724,873 |
0.5% |
797,000 |
0 |
0.388 |
N/A |
|
|
MASS |
908 Devices Inc. |
11 |
- |
$6.48 |
$1,791,000 |
237,258 |
0.43% |
-871,000 |
0 |
0.914 |
N/A |
|
|
CADL |
Candel Therapeutics, Inc. |
12 |
- |
$0.00 |
$1,283,000 |
811,737 |
0.31% |
90,000 |
0 |
2.829 |
N/A |
|
|
SPRB |
Spruce Biosciences, Inc. |
13 |
- |
$0.00 |
$622,000 |
787,007 |
0.15% |
-1,684,000 |
0 |
2.107 |
N/A |
|
|
ABSI |
Absci Corp |
14 |
- |
$4.21 |
$328,000 |
57,804 |
0.08% |
85,000 |
0 |
0.063 |
N/A |
|
|
IOT |
Samsara Inc. |
17 |
- |
$39.37 |
$135,000 |
3,570 |
0.03% |
16,000 |
0 |
0.001 |
N/A |
|
|
DDOG |
Datadog, Inc. |
18 |
- |
$0.00 |
$125,000 |
1,015 |
0.03% |
2,000 |
0 |
0 |
N/A |
|
|
GTLB |
Gitlab Inc. |
20 |
- |
$55.17 |
$38,000 |
658 |
0.01% |
-3,000 |
0 |
0.001 |
N/A |
|
